Embecta (FRA:JX7) COGS-to-Revenue : 0.37 (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Embecta COGS-to-Revenue?

Embecta's Cost of Goods Sold for the three months ended in Mar. 2025 was €88 Mil. Its Revenue for the three months ended in Mar. 2025 was €240 Mil.

Embecta's COGS to Revenue for the three months ended in Mar. 2025 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Embecta's Gross Margin % for the three months ended in Mar. 2025 was 63.36%.

Embecta COGS-to-Revenue Historical Data

The historical data trend for Embecta's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta COGS-to-Revenue Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

COGS-to-Revenue

Get a 7-Day Free Trial

0.30

0.31

0.33

0.35

Embecta Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial														0.35	0.30	0.39	0.40	0.37

Embecta COGS-to-Revenue Calculation

Embecta's COGS to Revenue for the fiscal year that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	349.498	/	1011.913
	=	0.35

Embecta's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	87.783	/	239.575
	=	0.37

Embecta (FRA:JX7) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Embecta's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	87.783 / 239.575
	=	63.36 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Embecta COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Embecta's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Headlines

No Headlines